Not checked for notices yet.

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment

Eduardo Duarte-Silva, Eduardo Duarte-Silva, Eduardo Duarte-Silva and 4 more

Frontiers in Neuroscience · 2022

doi:10.3389/fnins.2022.885031

References 70

1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
8.
Anti-inflammatory effects of spermidine in lipopolysaccharide-stimulated BV2 microglial cells · 2012
No notice
9.
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters · 2015
No notice
10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
11.
Regulation of immune cell function by short‐chain fatty acids · 2016
No notice
12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
13.
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls · 2016
No notice
14.
Alterations of the human gut microbiome in multiple sclerosis · 2016
No notice
15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
16.
The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models · 2017
No notice
17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
27.
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases · 2019
No notice
28.
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway · 2019
No notice
29.
The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes · 2019
No notice
30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
31.
Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice · 2019
No notice
32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
33.
Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation · 2019
Corrected
34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
37.
Gut microbial metabolites in depression: understanding the biochemical mechanisms · 2019
No notice
38.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
40.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library

All 70 references

Cited by papers we hold 1

Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases · 2022
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.